biote Corp (BTMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, biote Corp (BTMD) has a cash flow conversion efficiency ratio of -0.081x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.90 Million) by net assets ($-47.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of biote Corp for the company's overall valuation and market capitalisation.
biote Corp - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how biote Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
biote Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of biote Corp ranked by their cash flow conversion efficiency. Explore biote Corp earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
C I Systems
TA:CISY
|
0.039x |
|
Lokotech Group AS
OL:LOKO
|
-0.587x |
|
AC S.A.
WAR:ACG
|
0.102x |
|
EstechPharma Co. Ltd
KQ:041910
|
0.018x |
|
AViTA Corporation
TWO:4735
|
0.037x |
|
Histeel
KO:071090
|
0.121x |
|
Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA
F:MUT3
|
0.033x |
|
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
|
-0.003x |
Annual Cash Flow Conversion Efficiency for biote Corp (2019–2025)
The table below shows the annual cash flow conversion efficiency of biote Corp from 2019 to 2025. View today's stock price for biote Corp for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-50.40 Million | $35.19 Million | -0.698x | -57.75% |
| 2024-12-31 | $-102.20 Million | $45.24 Million | -0.443x | +39.82% |
| 2023-12-31 | $-36.55 Million | $26.88 Million | -0.736x | -568.12% |
| 2022-12-31 | $-58.27 Million | $-9.16 Million | 0.157x | -98.08% |
| 2021-12-31 | $4.12 Million | $33.72 Million | 8.175x | +628.21% |
| 2020-12-31 | $-17.07 Million | $26.43 Million | -1.548x | -100.99% |
| 2019-12-31 | $-32.93 Million | $25.35 Million | -0.770x | -- |
About biote Corp
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with … Read more